Status:
COMPLETED
A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)
Lead Sponsor:
Organon and Co
Conditions:
Asthma
Eligibility:
All Genders
2-14 years
Phase:
PHASE4
Brief Summary
A 53-week study to determine the effect of montelukast sodium when given to children (with infrequent episodic asthma) at the earliest symptoms of an acute episode of asthma.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Males or females between the ages of 2 and 14 who have infrequent episodic asthma.
Exclusion
Key Trial Info
Start Date :
June 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 14 2003
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT00140881
Start Date
June 1 2000
End Date
February 14 2003
Last Update
August 14 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.